Global accessibility of therapeutics for diabetes mellitus

Nat Rev Endocrinol. 2022 Apr;18(4):199-204. doi: 10.1038/s41574-021-00621-y. Epub 2022 Jan 17.

Abstract

Diabetes mellitus is a global health issue, yet huge regional disparities exist in its care, including in access to basic necessities such as insulin. In this Viewpoint, six experts from different regions discuss differences in access to insulin and other diabetes mellitus therapies as well as the key barriers in diabetes mellitus care accessibility and potential solutions.

MeSH terms

  • Diabetes Mellitus* / therapy
  • Diabetes Mellitus, Type 1*
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans